Pharma BD Deal Intelligence
2002 · Licensing/Option · $500M · Complete
Announced November 2002. Broad strategic alliance: Antisoma licensed virtually its entire pipeline to Roche. $43M upfront cash plus equity, $6.56M for a ~10% stake; potential $500M+ in milestones plus 10-20% royalties.
← Browse all deals · How we score deals